Introduction
Helicobacter pylori represents one of the most frequent causes for inflammatory processes of the gastrointestinal tract, gastric adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma. On account of its carcinogenic potential, H. pylori was the first bacterium classified as a class I carcinogen by the World Health Organization (WHO, 1994) . Its genome contains a cagpathogenicity island (cagPAI), encoding proteins for a specialized type IV secretion system (T4SS), which injects virulence factors directly into the host cytoplasm of infected epithelial cells. So far, peptidoglycans (Viala et al., 2004) and the CagA protein (Asahi et al., 2000; Backert et al., 2000; Odenbreit et al., 2000; Stein et al., 2000) are known to translocate into the infected epithelial host cell. Translocated CagA induces cellular processes, which lead to stimulation of cell dissemination followed by cell motility, and invasive growth in gastric epithelial cells (Segal et al., 1999; Bagnoli et al., 2005) . The molecular mechanisms leading to the CagAdependent dissemination of cell colonies are only partially known, but it became apparently clear that tyrosine phosphorylation of CagA is a crucial step in the epithelial cell migration (Selbach et al., 2002; Stein et al., 2002) . It was further hypothesized that phosphorylated CagA might function as an adapter protein to recruit eukaryotic proteins in a multi-protein and -enzyme complex, which includes zonula occludens-1 (ZO-1) (Amieva et al., 2003) , Src homology 2 domain tyrosine phosphatase (SHP-2) (Higashi et al., 2002) , Grb2 (Mimuro et al., 2002) , c-Met and phospholipase C-g (PLC-g) (Churin et al., 2003) and that it mediates signals leading to cell motility.
The Src family protein kinases c-Src, Fyn, Lyn and Yes were identified to phosphorylate the tyrosine of Glu-Pro-Ile-Tyr-Ala (EPIYA) motifs in the CagA molecule after its translocation and localization at the inner plasma membrane (Selbach et al., 2002; Stein et al., 2002) . The Src-mediated phosphorylation of CagA is followed by an inactivation of the catalytic activity of Src kinases resulting in the dephosphorylation of the actin-binding Src substrates ezrin and cortactin (Selbach et al., 2003; Selbach et al., 2004) . As Src kinases are rapidly inactivated, the sustained CagA phosphorylation observed in prolonged H. pylori infections must be accomplished by other molecular means (Selbach et al., 2003) .
Migratory cells are characterized by the extension of a leading lamellipodium with membrane ruffles, decreased focal contacts to the extracellular matrix, and loss of actin stress fibres. Recent evidence suggests that the non-receptor tyrosine kinase c-Abl regulates the actin cytoskeleton and influences cell morphology (Hernandez et al., 2004) . Among tyrosine kinases, c-Abl binds directly to F-actin. This is probably important for actin-generated structures involved in membrane ruffling, cell spreading and cell migration in response to growth factors and extracellular matrix signals (Plattner et al., 1999; Woodring et al., 2002) . Targets of c-Abl include the focal adhesion proteins paxillin (Lewis and Schwartz, 1998; Escalante et al., 2000) , p130Cas (Mayer et al., 1995) and c-CrkII (Feller et al., 1994a, b) . It has been demonstrated that phosphorylation of paxillin and p130Cas is connected to enhanced rates of cell spreading and migration. Tyrosine phosphorylation of CrkII probably negates these effects by uncoupling Abl-CrkCas or Abl-Crk-paxillin complexes (Mayer et al., 1995; Escalante et al., 2000; Kain and Klemke, 2001) . Despite these findings, the role of c-Abl in H. pylori-induced cell migration remained unexplored.
Here, we have identified the non-receptor tyrosine kinase c-Abl as a new target in H. pylori infection, which promotes epithelial cell elongation and motility. During infection, the kinase activity of c-Abl is enhanced, which leads to sustained phosphorylation of CagA translocated into the host.
Results

c-Abl is involved in H. pylori-induced cell motility
Infection of gastric epithelial cells with H. pylori causes a drastic cell elongation and migration (Al Ghoul et al., 2004; Moese et al., 2004) , which is strongly enhanced by CagA phosphorylation through Src family kinases (Selbach et al., 2002; Stein et al., 2002) . To investigate the influence of the non-receptor tyrosine kinase c-Abl on H. pylori-mediated cell motility, gastric epithelial adenocarcinoma cells were pretreated with different tyrosine kinase inhibitors before H. pylori infection. Compared to non-infected AGS cells (mock), noninhibited cells infected with H. pylori for 4 h (Hp) displayed the typical scattering phenotype characterized by the loss of cell contacts and drastic cell elongation ( Figure 1a , top panels). Preincubation of the cells with the inhibitors PP1 (inactivates Src and Abl family kinases), PP2 (inhibitor of Src family) and STI571 (a well characterized Abl, PDGFR and c-Kit inhibitor) before infection reduced cell elongation, whereas Figure 1 c-Abl is involved in cell motility. (a) AGS cells were incubated with tyrosine kinase inhibitors to block Src and c-Abl (30 mM PP1), Src (30 mM PP2), c-Abl (30 mM STI), platelet-derived growth factor receptor (PDGFR) (25 mM Ag1295), and epidermal growth factor receptor (EGFR) (250 nM Ag1478) or left untreated (mock). PP3 was used as a control. Phase-contrast microscopy was performed after 4 h of infection with H. pylori (Hp) with a MOI 100. (b) MKN-28 cells were preincubated with 10 mM STI for 1 h to block c-Abl kinase activity or left untreated (mock) followed by infection with H. pylori (Hp) for 48 h with a MOI 20 as indicated. Cell morphology was monitored by phase-contrast microscopy. (c) AGS cells were pretreated with increasing concentrations of STI571 followed by an infection with H. pylori for 6 h. The number of elongated cells was quantified and presented in a bar diagram. Data are expressed as mean 7 s.e.m. and asterisks indicate statistically significant differences (***Po0.001, **Po0.01). (d) Total RNA from AGS and MCF-7 cells was isolated and expression of indicated tyrosine kinases in response to H. pylori was analysed. GAPDH and c-Abl mRNAs were semiquantitated. As a control PCR was performed without prior reverse transcription (ÀRT).
c-Abl-induced CagA phosphorylation M Poppe et al controls PP3, AG1295 (PDGFR inhibitor) and AG1478 (EGFR blocker) did not affect the cellular phenotype ( Figure 1a ). These data indicate that, besides Src kinases, c-Abl might play an important role in cell motility induced by H. pylori, independently of PDGFR and EGFR activities. To confirm the effect of c-Abl in another gastric epithelial cell line, we included polarized MKN-28 cells in our study (Figure 1b) . A previous report indicated that the induction of the cell migration in H. pylori-infected MKN-28 cells is reduced (Bauer et al., 2005) . We observed after H. pylori infection for 48 h the typical cell scattering phenotype in MKN-28 cells (Figure 1b, top panels) . Preincubation of MNK-28 cells with STI571 to block c-Abl activity still allowed cell dissociation, but inhibited the elongation phenotype of H. pylori-infected MKN-28 cells (Figure 1b , lower panels). Similar results were obtained with human breast cancer MCF-7 cells (data not shown). To demonstrate the specificity of the c-Abl inhibitor STI571 cells were pretreated with increasing amounts and the number of elongated cells was quantified. A dose-dependent inhibition of cell elongation was observed, even a concentration of 1 mM STI571 significantly inhibited cell elongation ( Figure 1c) .
As the c-Abl inhibitor STI571 also blocks PDGFR and c-Kit, we further analysed whether mRNAs of c-abl, src, pdgfr and c-kit were expressed in gastric epithelial cells and whether expression is altered in response to H. pylori infection. Constant mRNA levels of c-abl, src, pdgfr and the control gapdh were observed in AGS cells, whereas expression of c-kit was not detected in AGS cells (Figure 1d , left panel). MCF-7 cells were also analysed and showed mRNA expression for c-kit, but not pdgfr (Figure 1d , right panel). These data suggest that the STI571 inhibited cell migration is owing to c-Abl inhibition and does not depend on c-Kit or PDGFR.
Localization of c-Abl in focal adhesion complexes Cytoplasmic c-Abl localizes to F-actin-associated cellular structures and focal adhesions, that act as peripheral docking sites for the F-actin bundles (Hernandez et al., 2004) . Thus, we determined the subcellular localization of c-Abl in H. pylori-infected MCF-7 cells. In noninfected cells, c-Abl mostly showed a homogenous distribution through the cytoplasm (Figure 2a, 1) . Co-staining with the focal adhesion protein vinculin (Figure 2a , 2) revealed little colocalization in mockinfected cells (Figure 2a The CagA tyrosine phosphorylation sites have been previously localized to the C-terminal EPIYA motifs that vary in number between CagA proteins from different H. pylori strains (Selbach et al., 2002; Stein et al., 2002) . To analyse whether the extent of c-Abl and Src-mediated CagA phosphorylation varies with the EPIYA repeats present in the CagA molecule, we detected the number and type of EPIYA motifs, in different clinical isolates using a recently published PCR protocol (Argent et al., 2005) . The EPIYA motif analyses of the H. pylori strains P1, P12 and Hp26695 are shown in Figure 4a . All tested CagA proteins possessed the EPIYA-A, EPIYA-B and one EPIYA-C motif, whereas two EPIYA-C motifs were only apparent in the P12 strain (Figure 4a (Barila et al., 2003; Machuy et al., 2004) . Instead, our data reveal that the total amount of c-Abl is increased in response to H. pylori infection (Figure 5c , second panel), which might account for target phosphorylation. As a control for equal protein loading, the p85 subunit of phosphoinositide-3 kinase (PI3K) was detected (Figure 5c , third panel).
c-Abl mediates sustained CagA phosphorylation To analyse the role of c-Abl and Src-dependent CagA phosphorylation, we generated a stable c-Abl knockdown AGS cell line (DAbl) using a shRNA expression vector. As a control, we created a stable AGS cell line using a scrambled control sequence (control). The Endogenous phospho-CrkII was analysed by immunoblotting using an anti-phospho-specific CrkII antibody. CrkII expression was detected using a non-phospho-specific CrkII antibody. (c) Phosphorylation of c-Abl Y245 was detected using a phosphospecific anti-c-Abl (Y245) antibody and cellular Abl and PI3K were detected using the indicated antibodies. As a positive control cells were stimulated with H 2 O 2 /vanadate for 15 min. were incubated with 30 mM PP2 for 1 h followed by an infection with H. pylori for 1 h or left untreated. CagA was immunoprecipitated from cell lysates and CagA phosphorylation was detected using the anti-phospho-tyrosine pY99 antibody. Immunoprecipitated CagA was detected using an anti-CagA antibody. Whole-cell lysates (WCL) were analysed for c-Abl and c-Src expression. As a loading control membranes were reprobed with an anti-PI3K antibody to demonstrate equal protein amounts. (b) SYF and reconstituted SYF þ Src cells were treated with H 2 O 2 /vanadate for 15 min to stimulate c-Abl activity. As indicated cell lysates were incubated with STI571 and with lysates of H. pylori wild type (P12) or its isogenic cagA mutant (P12 DCagA) for 30 min in an in vitro phosphorylation assay. Phosphorylated CagA was detected using the anti-phospho-tyrosine pY99 antibody. (c) Cell lysates from H 2 O 2 /vanadate-treated SYF and SYF þ c-Src cells were analysed for c-Abl, c-Src and PI3K expression using the indicated antibodies.
c-Abl-induced CagA phosphorylation M Poppe et al complexes in H. pylori-infected AGS cells (Figure 6d , upper panel). We still observed a presumably nonspecific cytoplasmic staining in DAbl cells using the antic-Abl antibody, but accumulation of c-Abl in focal adhesion complexes in H. pylori-infected DAbl cells was not detectable (Figure 6d, lower panel) .
To elucidate the effects of Src and Abl kinases in more detail, DAbl cells and the corresponding scrambled control cell line were pretreated with PP2 and infected with H. pylori for 1 h. CagA was immunoprecipitated and the phosphorylation of CagA was detected using the phospho-tyrosine antibody pY99 (Figure 7a , first panel). Unexpectedly, after infection for 1 h with H. pylori no significant difference between CagA phosphorylation in DAbl cells and negative control cells could be observed (Figure 7a, upper panel, compare lanes 3 and  7) . A complete inhibition of CagA phosphorylation, however, was obtained when cells were preincubated with PP2 to block Src kinases (Figure 7a , upper panel, compare lanes 4 and 8). No CagA phosphorylation was detected using cagPAI-deficient H. pylori mutants for infection experiments (data not shown). Equal amounts of CagA, c-Abl, Src and cellular PI3K were demonstrated in lower panels of Figure 7a . Selbach et al. (2002) have previously shown that CagA was not phosphorylated in mouse fibroblasts deficient in c-Src, Yes and Fyn (SYF cells). To analyse whether c-Abl in SYF cells can phosphorylate CagA, cells were treated with H 2 O 2 /vanadate to elevate c-Abl activity. As a control, stimulated SYF cells that stably re-expressed c-Src (SYF þ Src) were included in this analysis. As indicated cellular SYF lysates were incubated with H. pylori sonicates from the H. pylori strain P12 containing CagA and STI571. Lysates from stimulated SYF þ Src cells phosphorylated CagA, which is slightly reduced when lysates from SYF cells were used (Figure 7b, lanes 1-2) . STI571-treated SYF þ Src cell lysates displayed a weaker phosphorylation of CagA, which was completely blocked in lysates from STI571-treated SYF cells (Figure 7b, lanes 3-4) . These data indicate that c-Abl can phosphorylate CagA in Src kinase-deficient cells. Lysates of a cagA-negative H. pylori mutant were used as a negative control (Figure 7b , lanes 5-6). Figure 7c shows that H 2 O 2 /vanadate-treated SYF cells contain an increased level of c-Abl (Figure 7c ).
As we observed that two different tyrosine kinases directly phosphorylate CagA, we asked whether they play distinct roles in H. pylori infections. We observed that phosphorylation of CagA is steadily increased in cells infected with H. pylori (Figure 8a, lanes 1-5, first  panel) . Analysing the kinetic of activated Src, we found that Src is activated at 30 min and 1 h, but inactivated after 2 h postinfection (Figure 8a, lanes 1-4, third  panel) . As controls cells were stimulated with the phorbol ester PMA to stimulate Src kinase activity (Figure 8a , lane 6) and CagA and Src were detected to demonstrate equal protein loading (Figure 8a , second and fourth panels). Compared to the Src kinetic, we detected a delayed c-Abl activation as monitored by phosphorylation of the c-Abl substrate GST-CrkII phosphorylation in vitro (Figure 8b, upper panel) . These data indicate that there is a time shift in the activation of c-Abl and Src kinases which probably explains why CagA is still phosphorylated whereas Src is already inactivated and relatively high concentrations of STI571 are needed to block CagA phosphorylation in early phases of H. pylori infections (Figure 3b ). To test this hypothesis, MKN-28 cells were subjected to short-term (Figure 8c , upper panels) and long-term infection (Figure 8c , lower panels) with H. pylori. We observed a clear reduction of CagA phosphorylation induced by H. pylori infection for 4 h using low doses of PP2, whereas low concentrations of STI571 had no effect on CagA phosphorylation (Figure 8c, upper panel, lanes  3-4) . In contrast to these results, sustained CagA phosphorylation in H. pylori infection for 12 h was only were incubated with 100 nM PMA for 15 min. CagA was immunoprecipitated from cell lysates and CagA phosphorylation was detected using an anti-phospho-tyrosine antibody. Immunoprecipitated CagA was detected using an anti-CagA antibody. Cell lysates were analysed for activated Src kinases using an antiphospho-Src antibody. As a loading control immunoblots were reprobed using an non-phospho-specific antibody for c-Src. (b) Immunoprecipitated c-Abl from AGS cells infected with H. pylori for the indicated time periods was incubated with 5 mg GSTc-CrkII as a substrate for c-Abl in an in vitro phosphorylation assay. Phosphorylation of GST-CrkII was visualized using a phospho-specific antibody for CrkII. As a control GST-CrkII was detected using an anti-GST antibody to demonstrate equal substrate protein in all lanes. (c) MKN-28 cells were left untreated or incubated with 5 mM STI or 5 mM PP2 for 1 h before infection with H. pylori for the indicated periods. Tyrosine phosphorylated proteins were immunoprecipitated from cell lysates using an antiphospho-tyrosine antibody and phosphorylated CagA was detected using an anti-CagA antibody. As a control CagA was detected in cell lysates using an anti-CagA antibody.
c-Abl-induced CagA phosphorylation M Poppe et al inhibited using STI571, but not in response to PP2 in lower doses (Figure 8c, lower panel, lanes 3-4) . These data clearly show that Src and c-Abl play a distinct role in H. pylori infections.
Discussion
The pathogenic factor CagA of H. pylori is clearly associated with the development of gastric cancer. CagA translocates through a type IV secretion system into the cytoplasm of infected cells, where it localizes to the plasma membrane, is tyrosine phosphorylated through Src family kinases (Selbach et al., 2002; Stein et al., 2002) and evokes cell elongation (Backert et al., 2001) . In this study, we identified c-Abl as another tyrosine kinase that can directly phosphorylate CagA and promote cell migration. CagA tyrosine phosphorylation sites have been described in its EPIYA repeats, which show similarity to the Src phosphorylation consensus EEIY(G/E). However, different protein tyrosine kinases often show overlapping specificity. c-Abl is known to phosphorylate the EPGYAQP motif of CrkII (Feller et al., 1994a) and HSPYAQP motif of p73 (Yuan et al., 1999) that also share some homology with EPIYA motifs of CagA. Although it has been proposed in vitro that the EGFR can phosphorylate CagA (Asahi et al., 2000) , the EGFR substrate consensus phosphorylation motif EEEYF exhibits only weak similarity to the EPIYA motif of CagA. Our data presented here do not support an essential role for EGFR in living cells, because inhibition did not block cell motility or CagA phosphorylation.
CagA proteins from Western H. pylori strains possess up to five EPIYA motifs. The first and second EPIYA motifs are conserved among CagA proteins and have been designated as EPIYA-A and EPIYA-B, respectively. These motifs are followed by a varying number of EPIYA-C motifs that are considered to be the major phosphorylation sites in CagA (Hatakeyama, 2004) . We found that three EPIYA motifs are sufficient for an effective CagA phosphorylation by Src and c-Abl, but further studies are necessary in the future to analyse the detailed Src-and c-Abl targeted EPIYA motifs.
The molecular mechanisms leading to activation of c-Abl are only partly understood. Kinase activity of cAbl can be regulated via phosphorylation of tyrosines 412 and 245 (Hantschel and Superti-Furga, 2004 ) but additional modes of regulation have been reported. Interestingly, we did not find induced phosphorylation of Y412 and Y245 of endogenous or even overexpressed and immunoprecipitated c-Abl upon infection with H. pylori. Although we detected tyrosine phosphorylated c-Abl after cell treatment with H 2 O 2 /vanadate, we suppose that c-Abl phosphorylation is probably too weak in response to H. pylori infection for the detection using phospho-specific c-Abl antibodies. Another explanation for the lack of phospho-c-Abl detection may be the proteasome pathway that degrades phosphorylated c-Abl in some cells (Echarri and Pendergast, 2001 ). Instead of induced phosphorylation, we observed an increase of the c-Abl protein level, that is probably the result of protein stabilization because infection with H. pylori did not induce an increase of c-Abl mRNA. Consequently, we suggest that enhanced c-Abl kinase activity is probably mediated through accumulation of c-Abl in H. pylori-infected cells.
It has been previously described that Src kinases are inactivated upon CagA phosphorylation that leads to tyrosine dephosphorylation of several host cell proteins (Selbach et al., 2003 . However, the question was still open why CagA phosphorylation increases in sustained H. pylori infections, even though Src kinases are inactivated. Comparison of Src and c-Abl activation revealed different kinase activation kinetics in H. pyloriinfected cells. Src kinases were rapidly phosphorylated within 1 h, but dephosphorylated 2 h postinfection. Activation of c-Abl was only slightly increased within the first hour of infection, but strongly induced after 2 h. These different kinetics might explain why high concentrations of the c-Abl inhibitor STI571 were needed to block CagA phosphorylation whereas low inhibitor doses were sufficient to block sustained CagA phosphorylation in prolonged H. pylori infections. CagAmediated Src inactivation leads to dephosphorylation of cellular Src substrates such as ezrin and cortactin (Selbach et al., 2003 , whereas H. pylori-induced c-Abl activity leads to activation of c-Abl specific substrates such as Crk proteins in successive processes. We conclude from our study that Src and c-Abl kinases play differential roles in infected epithelial cells.
It is well established that c-Abl also plays an important role in normal cell shape changes and cell migration (Frasca et al., 2001; Kain and Klemke, 2001) . Tyrosine phosphorylation of the c-Abl target c-CrkII can be one important step. CrkII-pY221 departs from the Cas-Crk complex, resulting in decreased cell migration and promotion of apoptosis in certain cells (Kain and Klemke, 2001) . However, here, we demonstrated that c-Abl kinase activity is necessary for H. pylori-mediated cell motility that is in line with a very recent report demonstrating for the first time in non-hematopoietic cells that deregulated c-Abl promotes invasive growth (Srinivasan and Plattner, 2006) . Interestingly, it was very recently published that phosphoCagA also interacts with Crk proteins and that this interaction is crucial to induce H. pylori-dependent cell migration (Suzuki et al., 2005) . This pathway possibly involves Crk/Dock180/Rac1/WAVE signalling, leading to actin reorganization (Suzuki et al., 2005) . Therefore, we presume that c-Abl-mediated Crk and CagA phosphorylation may also induce Rac1-dependent cytoskeletal rearrangement of the infected host cell. c-Abl may thus represent a target for the therapy of H. pyloriinduced inflammatory disease and neoplasia.
Materials and methods
Cell culture and infection
The human breast cancer cell line MCF-7, and the human gastric adenocarcinoma cell lines AGS and MKN-28 were c-Abl-induced CagA phosphorylation M Poppe et al grown in RPMI 1640 medium containing 4 mM glutamine (Invitrogen, Karlsruhe, Germany), and 10% fetal calf serum (FCS) (Biowest, Nuaille´, France) in a humidified 5% CO 2 atmosphere. The mouse fibroblast cell lines SYF and SYF þ c-Src were grown in Dulbecco's modified Eagle's medium (DMEM) containing 4 mM glutamine, and 10% FCS in a humidified 10% CO 2 atmosphere. Cells were seeded in tissue culture plates for 48 h before infection and serum-starved for 16 h. Phase-contrast microscopy was performed using an inverted microscope (model TS 100, INTAS). H. pylori strains P1, P12 and Hp26695 and their isogenic mutants DCagA and DPAI have been described elsewhere (Schmitt and Haas 1994; Corthesy-Theulaz et al., 1996; Tomb et al., 1997; Odenbreit et al., 2000; Wessler et al., 2000) . Bacteria were cultured on agar plates containing 10% horse serum under microaerophilic conditions at 371C for 48 h. For infection, bacteria were harvested in phosphate-buffered saline (PBS), pH 7.4 and added to the host cells at a multiplicity of infection (MOI) of 100 for the indicated periods of time. Where indicated, cells were stimulated with 100 nM PMA or 10 mM H 2 O 2 /100 mM sodium vanadate or pretreated with PP1 to block Src and Abl kinases, PP2 to block Src kinases, AG1295 to block PDGFR, PP3 or AG1478 to block EGFR (Merck Biosciences GmbH, Bad Soden/Ts., Germany), and STI571 to block c-Abl (Novartis, Basel, Switzerland). All experiments were repeated three-four times.
Immunoprecipitation, Western blot analysis and kinase assays Cells were harvested in lysis buffer (20 mM Tris pH 7.5, 1 mM EDTA, 100 mM NaCl, 1% Triton X-100, 0.1% SDS, 1 Â complete protease inhibitor tablets (Roche Diagnostics, Mannheim, Germany), 1 mM sodium molybdate, 20 mM NaF, 10 mM sodium pyrophosphate, 20 mM b-glycerophosphate, 1 mM sodium vanadate). Proteins were subjected to Western blot analysis using anti-phospho-tyrosine (pY99), anti-c-Abl (24-11), anti-c-Src, anti-Calnexin, anti-CrkL, antiCrkII antibodies (Santa Cruz Biotechnology, Heidelberg, Germany), anti-PI3K p85 (Upstate, Hampshire, UK), antiCagA antibody (Aalto Bio Reagents Ltd., Dublin, Ireland), anti-b-catenin (BD Biosciences, Heidelberg, Germany), and anti-GST. Anti-phospho-CrkL (Tyr207), anti-phospho-CrkII, anti-phospho-c-Abl (Y245), anti-phospho-c-Abl (Y412), and anti-phospho-Src (Y416) antibodies were obtained from New England Biolabs, Frankfurt/Main, Germany. For immunoprecipitation experiments, lysates were incubated with 5 mg anti-c-Abl (24-11), anti-CagA antibodies (Immunological and Biochemical Testsystems GmbH, Reutlingen, Germany), or preimmuneserum. Immunocomplexes were analysed in Western blot analysis for interacting proteins. For in vitro phosphorylation assays, immunocomplexes were incubated with 5 mg GST-c-CrkII (Feller et al., 1994a) or PKC in 250 mM ATP, 20 mM (4-2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) pH 7.4, 10 mM MgCl 2 and 10 mM MnCl 2 . Recombinant c-Abl and Src proteins were obtained from Biomol (Hamburg, Germany). For in vitro phosphorylation of CagA, H. pylori was sonicated in kinase buffer containing 0.5% NP-40 and aliquots of lysate were incubated with recombinant kinases. Phospho-CagA was detected in Western blot analysis using the anti-phospho-tyrosine antibody pY99. Where indicated, CagA was immunoprecipitated before in vitro phosphorylation.
Immunofluorescence Cells were grown on glass coverslips and serum starved for 18 h before infection. Cells were fixed (4% paraformaldehyde in PBS), permeabilized (0.2% Triton X-100 in PBS), and blocked in 1% bovine serum albumin (BSA). Cells were stained with anti-c-Abl (K12) from Santa Cruz Biotechnology, anti-Vinculin (MAB3574) from Chemicon Europe (Hampshire, UK), Alexa Fluor 546 phalloidin (Invitrogen, Karlsruhe, Germany), and DAPI (Roche Diagnostics, Mannheim, Germany). All steps were performed at room temperature.
Subcellular fractionation
To obtain the plasma membrane fraction, cells were harvested in HLB buffer (10 mM Tris pH 7.5, 1 mM ethylene glycol bis(baminoethylether)-N,N,N 0 ,N 0 ,-tetraacetic acid (EGTA), 1 mM ethylenediaminetetraacetic acid (EDTA), 10 mM KCl, 2 mM MgCl 2 , 1mM dithiothreitol (DTT), 1 Â complete protease inhibitor tablets, 1 mM sodium molybdate, 0.3 mM sodium vanadate), incubated on ice for 20 min, and dounce homogenized. The lysate was centrifugated for 30 min at 1000 g. The supernatant was centrifuged again at 10 000 g for 30 min, and the resulting supernatant was centrifuged at 100 000 g for 1 h at 41C. The 100 000 g pellet was resuspended in lysis buffer. All steps were performed at 41C. The ER fraction was prepared as described previously (Ito et al., 2001) .
Generation of stable c-Abl knock-down cells
The shRNA vector containing the sequence for a c-Abl siRNA was constructed using the pSilencer2.1t-U6 hygro System (Ambion, Huntingdon, UK). The siRNA sequence of c-Abl was obtained from Ambion. As a negative control, a scrambled sequence was used, which has no homology to any mammalian gene. The vectors were constructed following the manufacturer's instructions and transfected into AGS cells using Effectene transfection reagent (Qiagen, Hilden, Germany). 0 . PCR conditions were as follows: 951C for 5 min followed by 25 cycles of 951C (30 s), 561C (30 s) and 721C (30 s) and a final elongation at 721C (10 min). All reactions containing c-Abl primers were performed with 35 cycles. The PCR was performed using Taq DNA Polymerase (Amersham Biosciences Europe GmbH, Freiburg, Germany) and 20 pmol primers were used, whereas in semi-quantitative PCR 10 pmol glyceraldehydes-3-phosphate dehydrogenase and 30 pmol c-Abl primers were used. Analysis of EPIYA motifs present in CagA has been previously described in detail (Argent et al., 2005) .
